Guilin Medical Univ. CA IX compound 7m

Guilin Medical Univ. CA IX compound 7m: sourced facts only. name: "Additionally, 7m exhibits potent inhibitory activity against CA IX (IC50 = 80.45 ± 39.7 nM) and shows enhanced antitumor activity under hypoxic conditions compared to normoxic conditions." [PMID:40515697]; target: "Additionally, 7m exhibits potent inhibitory activity against CA IX (IC50 = 80.45 ± 39.7 nM) and shows enhanced antitumor activity under hypoxic conditions compared to normoxic conditions." [PMID:40515697]; developer: "Guangxi Key Laboratory of Drug Discovery and Optimization, School of Pharmacy, Guilin Medical University, Guilin 541004, China." [PMID:40515697]; stage: "The representative compound 7m demonstrated significant antitumor effects against the MDA-MB-231 cell line both in vitro and in vivo." [PMID:40515697]